Clinical-stage biopharmaceutical equities like aTyr Pharma (NASDAQ: LIFE) carry high volatility. Wall Street analysts generally classify pre-revenue biotech firms based on upcoming clinical trial catalysts and pipeline data readouts rather than traditional value metrics.